Yahoo Web Search

Search results

1. • 

     Exelixis' XL092/ Atezolizumab Shows Encouraging Efficacy, Safety In Heavily Pretreated Cancer...

     Benzinga via Yahoo Finance· 2 years ago

     Exelixis Inc (NASDAQ: EXEL) announced results from the dose-escalation stage of STELLAR-001, an...

2. • 

     England to rollout world-first seven-minute cancer treatment jab

     Reuters via Yahoo News· 9 months ago

     Following approval from the Medicines and Healthcare products Regulatory Agency (MHRA), NHS England...

3. • 

     Exelixis (EXEL) Begins Study on XL092 Combo in Colorectal Cancer

     Zacks via Yahoo Finance· 2 years ago

     Exelixis (EXEL) starts the phase III STELLAR-303 study evaluating XL092 in combination with...

4. • 

     Phanes Therapeutics signs clinical supply agreement with Roche

     Clinical Trials Arena via Yahoo Finance· 2 weeks ago

     US-based biopharmaceutical company Phanes Therapeutics has announced a clinical supply agreement...

5. • 

     Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo

     Benzinga via Yahoo Finance· 1 year ago

     Exelixis Inc (NASDAQ: EXEL) announced that the phase 3 CONTACT-03 study did not meet its primary...

6. • 

     Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More

     Zacks via Yahoo Finance· 1 year ago

     The biotech sector was in focus with key pipeline and regulatory updates. Among these, BMRN was down...

7. • 

     Biotech Stock Roundup: GLTO Plunges on Setback, BLUE Offers Updates & More

     Zacks via Yahoo Finance· 9 months ago

     It was a low-key week for the biotech sector as the earnings season ended and nothing much came from...

8. • 

     Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting

     Benzinga via Yahoo Finance· 1 year ago

     Exelixis Inc (NASDAQ: EXEL) announced that the CONTACT-01 study did not meet its primary endpoint of...

9. • 

     Brazilian soccer legend Pelé died of colon cancer. Here are the cutting-edge clinical trials trying...

     Business Insider via Yahoo News· 1 year ago

     Pelé died of colon cancer, one of the most common types.Clive Mason/Getty The Brazilian soccer...

10. • 

      Exelixis' (EXEL) Prostate Cancer Study Meets Primary Endpoint

      Zacks via Yahoo Finance· 9 months ago

      Exelixis, Inc. EXEL and partner Ipsen announced that the late-stage CONTACT-02 study achieved one of...